Regulacje i polityka gospodarcza · 28/12/2021

National Cancer Institute to Grant Exclusive Patent License for Anti-Viral Infections Treatment and Prevention

The National Cancer Institute is considering granting an exclusive, sublicensable patent license to the University of Louisville Research Foundation for its rights to certain inventions and patents related to Griffithsin compositions for treating and preventing anti-viral infections, with ULRF acting as the agent for the University of Louisville.